PDE4 inhibitors (Scottish Biomedical)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug NamePDE4 inhibitors (Scottish Biomedical)

Drug Alias Namepseudothiohydantoin derivatives (Scottish Biomedical)rhodanine derivatives (Scottich Biomedical)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPhosphodieterase 4 inhibitors

TargetsPhosphodieterase 4

Therapy Area/IndicationsInflammation

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryWorld

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSB Drug Discovery

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesSB Drug Discovery

Active IndicationsN/A

Inactive IndicationsInflammation

ATC CodeN/A